Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02892474 · ClinicalTrials.gov registry record

HCR vs. CABG Study

A clinical trial of Coronary Artery Disease, sponsored by Emory University.

Completed
Registry status
75
Enrollment target
1
Study location

NCT02892474 is a study of Coronary Artery Disease that has completed, run by Emory University. The registered enrollment target is 75 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02892474, a study of Coronary Artery Disease, has completed, sponsored by Emory University.

COMPLETED
Registry status
75 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to find out if hybrid coronary revascularization (HCR) and coronary artery bypass grafting (CABG) procedure outcomes are similar. HCR is a combination of surgery and catheter procedures to open up clogged heart arteries. CABG is a surgical procedure to open up clogged heart arteries.

Conditions Studied

Interventions

  • PROCEDURE Hybrid Coronary Revascularization (HCR)
  • PROCEDURE Coronary Artery Bypass Grafting (CABG)

Study Locations (1)

Georgia

  • Emory University Hospital Midtown - Atlanta

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2016-08
Est. Completion 2018-07-27

Sponsor

Emory University

1,208 total trials

What the Registry Record Tells You About NCT02892474

The ClinicalTrials.gov registry entry for NCT02892474 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (94% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which Hybrid Coronary Revascularization (HCR) is the first listed.

NCT02892474 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT02892474 about?

NCT02892474 is a clinical study titled "HCR vs. CABG Study". The purpose of the study is to find out if hybrid coronary revascularization (HCR) and coronary artery bypass grafting (CABG) procedure outcomes are similar. HCR is a combination of surgery and catheter procedures to open up clogged heart arteries. CABG is a surgical procedure to open up clogged hea...

What is the current status of trial NCT02892474?

This trial is currently completed. The enrollment target is 75 participants. The study started on 2016-08. Estimated completion is 2018-07-27.

What conditions does trial NCT02892474 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT02892474?

The interventions under investigation include: Hybrid Coronary Revascularization (HCR) (PROCEDURE), Coronary Artery Bypass Grafting (CABG) (PROCEDURE).

Who is sponsoring clinical trial NCT02892474?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02892474 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.